The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here.
Testing hub situated in SOHO, centre of Theatre Land, 25,000+ per night when full, previous experience/relationships.
Katalyst Laboratories has experience in delivering rapid, onsite, COVID-19 testing solutions for Westend theatres. Our Testing Hub in Soho, London can directly support the testing requirements for all West End theatres.
https://katalystlaboratories.com/re-open-theatres/
Agreed, but all 52 passengers on this one flight? Nah, crappy tests i think.
Again how many other flights had Covid passengers.
Not sure how you could test a plane load (350 - 400) passengers before a flight, especially when there are 10-15 flights an hour taking off. Where do you put 3,000, 4,000, 5,000 people per hour? You'd need a small stadium for that volume
"THREAT TO THE WORLD Fifty-two passengers on flight from Delhi to Hong Kong test positive for Covid – despite negative result pre-flight"
******************************************************************************
Yes, wonder how many flights WorldWide left Delhi with Covid positive passengers?
Whose tests did they use I wonder?
Saw a Modi political rally (approx 8/10 days ago), Tens & Tens of thousands packed together, No Masks? No Social Distancing
Not good .....
A cluster of families in Telford have tested positive for a mutation of the UK Covid-19 variant, a council said.
https://www.bbc.co.uk/news/uk-england-shropshire-56864174
Thanks Kaeren
On twitter is it possible to Reply/Tag/Add In this to the
"COVID-19 Tweets from UK authorities" group as it appears to have Hanc0ck/Sturgeon/Boris and other groups/dignatories attached.
They may like a simple roadmap?
Don't forget to Register for the next Webinar - 7th May
An invitation from Professor Roberto André Kraenkel to join our webinar, 07 May, where he will discuss #COVID19 Variants of Concern, alongside the rest of our global panel of highly respected experts.
Register today: https://bit.ly/3n5jrHM
R&D highlights
· Expansion of PathFlow® lateral flow test (LFT) portfolio with COVID-19 tests
o Launch of LFT to detect SARS-CoV-2 IgG antibodies
o Development of LFT to detect and differentiate between SARS-CoV-2 IgG antibodies, launch expected Q3 2021
o Development of LFT to detect antigens for SARS-CoV-2, launch expected by end of Q2 2021
· Expansion of genesig® COVID-19 polymerase chain reaction (PCR) portfolio
o Launch of CE Mark three-gene target PCR test
· Expansion of PROmate™ COVID-19 PCR portfolio for workflow efficiency in a near-to-patient setting
o Development of two-gene target test, launch expected May 2021
o Launch of test to identify a key mutation, E484K, found in all current variants of concern (VOC)
· Expansion of SNPsig® COVID-19 PCR genotyping portfolio to detect SARS-CoV-2 variants
o Launch of CE Mark VariPLEX™ assay panel to detect multiple variants
o Development of test to detect a variant originally identified in India, launch expected week commencing 26 April 2021
UK operational highlights
· Expansion of UK commercial infrastructure
· Inclusion in Public Health England (PHE) National Framework Agreement
Graham Mullis, Chief Executive Officer of Novacyt, commented:
"The continued development and expansion of our COVID-19 portfolio demonstrates Novacyt's ability to match the rapid evolution of SARS-CoV-2 with real-time bioinformatics surveillance and accelerated product development. We remain committed to identifying patient needs and overcoming healthcare challenges today and in the years ahead as we continue to strengthen our position as a leading innovator in diagnostic testing.
"We are also pleased to be included in the PHE national framework, which allows PHE and NHS hospitals to purchase our accredited products without the need for direct contract awards. We look forward to the opportunity to expand our support of diagnostic testing in the UK through our established infrastructure and building a long-term future in this important market, as well as in international markets as we continue to invest in our direct commercial operations."
Last Years RNS's relating to Year End 2019 results were:
In 2020:
30th June - Publication of Annual Report
14th May - Final results for 31 Dec 2019
29th Apr - Notification of Publication of final Results
Therefore, could we see the Final Results and Outlook for 2021 some time in Mid May (as last year), and then the Full Audited Annual Results 29th June?
Can anybody confirm that I'm reading this correctly please
Accounts
Required to publish accounts from 1 January to 31 December within 4 months under parent law.
(I think last year all companies were granted an extension if they needed it)
https://find-and-update.company-information.service.gov.uk/company/FC033649
Graham Mullis, Group CEO of Novacyt, commented:
"Novacyt remains focused on leveraging its innovative reputation and position in the rapidly changing COVID-19 testing market to continue to deliver value and support clinicians and laboratories in a global setting. Of note, following its launch, our PROmate™ test has been well received by users and opens up new opportunities for rapid PCR testing, including in private testing markets.
In addition, we look forward to presenting exciting long-term plans for Novacyt during Q2 this year as we continue to define our strategy for delivering sustainable, long-term growth."
Wonder how many countries have current tests that can detect this Indian ‘Double’ variant?
There are 4 - 5 Billion people in Middle East + Asia, so if this spreads as quickly and powerfully as being mentioned, many countries could coming knocking.
Already it has doubled here in less than a week, how many cases in India this week alone? 1.5m?
A 'double mutant' variant of COVID-19 virus found in India is a cause of growing concern.
The variant, named B.1.617, has been found in more than 60% of the sequenced samples from Maharashtra and also detected in nine other states of the country, say news reports. The government has said higher transmissibility of this variant has not been established yet. The United Kingdom is the latest country to have discovered the "double mutation" variant in its region.
The 'double mutant' #COVID strain may have become the most prevalent strain in the recent cases of infection across #India.
https://twitter.com/i/events/1383065171132772352
One positive we might see is a token dividend to shareholders to reward our patience
************************************************************************************
Rather they spend £20m and do a share Buy Back of approx 5m shares.
That'll help the SP Up and panic the shorters into Buying, therefore helping the SP even further